2,4,5-Trifluorophenylacetic Acid CAS 209995-38-0 Mimọ ≥99.5% (GC) Sitagliptin Phosphate Monohydrate Agbedemeji Aworan Ifihan

2,4,5-Trifluorophenylacetic Acid CAS 209995-38-0 Mimọ ≥99.5% (GC) Sitagliptin Phosphate Monohydrate Intermediate

Apejuwe kukuru:

Orukọ Kemikali: 2,4,5-Trifluorophenylacetic Acid

CAS: 209995-38-0

Mimọ: ≥99.5% (GC)

Irisi: Funfun si Paa-White Powder

Aarin ti Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9) fun itọju iru àtọgbẹ 2.

Didara to gaju, iṣelọpọ Iṣowo

E-Mail: alvin@ruifuchem.com

Fi imeeli ranṣẹ si wa

Alaye ọja

Jẹmọ Products

ọja Tags

Apejuwe:

Ipese Sitagliptin Phosphate Monohydrate Awọn agbedemeji ibatan:
Sitagliptin API CAS 486460-32-6
Sitagliptin Phosphate Monohydrate API CAS 654671-77-9
2,4,5-Trifluorophenylacetic Acid CAS 209995-38-0
Boc-(R) -3-Amino-4- (2,4,5-Trifluoro-Phenyl) -Butyric Acid CAS 486460-00-8
Sitagliptin Triazole Hydrochloride CAS 762240-92-6
Sitagliptin Phosphate Monohydrate Agbedemeji CAS 486460-21-3

Kemikali Properties:

Orukọ Kemikali	2,4,5-Trifluorophenylacetic Acid
Nọmba CAS	209995-38-0
NỌMBA CAT	RF-PI1191
Iṣura Ipo	Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn Toonu
Ilana molikula	C8H5F3O2
Òṣuwọn Molikula	190.12
Ojuami Iyo	121.0 si 125.0 ℃
Solubility	Tiotuka ni kẹmika
Brand	Ruifu Kemikali

Awọn pato:

Nkan	Awọn pato
Ifarahan	Funfun to Pa-White Powder
Mimọ / Analysis Ọna	≥99.5% (GC)
Ọrinrin (KF)	≤0.50%
Aloku lori Igniton	≤0.50%
Lapapọ Awọn Aimọ	≤0.50%
Igbeyewo Standard	Standard Enterprise
Lilo	Agbedemeji Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9)

Package & Ibi ipamọ:

Package: Igo, apo apamọwọ Aluminiomu, 25kg / Paali Drum, tabi gẹgẹbi ibeere alabara.

Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina ati ọrinrin.

Awọn anfani:

FAQ:

Ohun elo:

2,4,5-Trifluorophenylacetic Acid (CAS: 209995-38-0) jẹ agbedemeji Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9).Sitagliptin Phosphate (STG) ni a lo lati ṣe itọju DM iru 2 nitori pe o mu iṣakoso glycemic pọ si nipa jijẹ awọn ipele ti awọn homonu incretin ti nṣiṣe lọwọ, GLP-1 (peptide-1) ati GIP (glucose-based insulinotropic peptide).Iṣiṣẹ ti awọn incretin wọnyi ni awọn sẹẹli β-pancreatic fa awọn ipele ti o pọ si ti adenosine monophosphate cyclic (cAMP) ati kalisiomu intracellular, pẹlu yomijade insulini ti o gbẹkẹle glukosi ti o tẹle (2).Oogun hypoglycemic yii jẹ ti kilasi tuntun ti a pe ni dipeptidyl peptidase IV inhibitors.STG ti fọwọsi nipasẹ FDA ni ọdun 2006.